FDA.reportPublic FDA data

Tecartus 200,000,000 CELLS in 68 ML Injection

RxCUI
2387352
RxNorm name
Tecartus 200,000,000 CELLS in 68 ML Injection
Display name
Tecartus 200,000,000 CELLS in 68 ML Injection
Full name
Tecartus 200,000,000 CELLS in 68 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125703TecartusBrexucabtagene Autoleucel351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TECARTUSBREXUCABTAGENE AUTOLEUCELKite Pharma, Inc.a16108c2-7ca7-45af-965e-54bda47130222026-06-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2387352

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a16108c2-7ca7-45af-965e-54bda4713022Tecartus 200,000,000 CELLS in 68 ML InjectionPSN16These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 202020260401
a16108c2-7ca7-45af-965e-54bda471302268 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection [Tecartus]SBD16These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 202020260401
a16108c2-7ca7-45af-965e-54bda471302268 ML Tecartus 2940000 CELLS/ML InjectionSY16These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 202020260401
a16108c2-7ca7-45af-965e-54bda4713022Tecartus 200,000,000 CELLS per 68 ML InjectionSY16These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 202020260401